Eurocom wins brief with Galderma

Eurocom Healthcare Communications has won a new contract with international dermatology company Galderma following a competitive pitch.

The agency has been appointed to handle a range of the firm's consumer healthcare dermatology brands. The work on the self-medication brands portfolio will involve a number of established products, as well as several forthcoming launches.

Galderma is one of the fastest growing pharmaceutical companies within the UK, offering a selection of prescription products, over-the-counter medications and corrective and aesthetic procedures.

Its global business encompasses 34 wholly-owned affiliates and a worldwide network of distributors, over 5,000 employees and a commercial presence in 80 countries.

Tony Chant, managing director at Eurocom, said: "Galderma is a world leader in dermatology, so we are delighted to have been awarded the self-medication brands portfolio for the UK."

The agency's other healthcare sector clients include major organisations such as Teva, Leo Pharma, ProStrakan, Smith and Nephew and Ferring Pharmaceuticals.